1718 related articles for article (PubMed ID: 8299185)
21. [The hierarchization of the prognostic factors in uveal malignant melanoma].
Călugăru M; Mera M; Călugăru D
Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
[TBL] [Abstract][Full Text] [Related]
22. [Study of the lymphocyte blast transformation reaction as a criterion of prognosis in the outcome of treatment of uveal melanoblastomas].
Kotelianskiĭ EO
Oftalmol Zh; 1986; (7):407-9. PubMed ID: 3493458
[No Abstract] [Full Text] [Related]
23. Expression of cyclin-D1 in uveal malignant melanoma.
Errico ME; Staibano S; Tranfa F; Bonavolonta G; Lo Muzio L; Somma P; Lucariello A; Mansueto G; D'Aponte A; Ferrara G; De Rosa G
Anticancer Res; 2003; 23(3B):2701-6. PubMed ID: 12894561
[TBL] [Abstract][Full Text] [Related]
24. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J; Nilsson LM; Mitra S; Alsén S; Shelke GV; Sah VR; Forsberg EMV; Stierner U; All-Eriksson C; Einarsdottir B; Jespersen H; Ny L; Lindnér P; Larsson E; Olofsson Bagge R; Nilsson JA
Nat Commun; 2020 Apr; 11(1):1894. PubMed ID: 32313009
[TBL] [Abstract][Full Text] [Related]
26. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
Canovas D; Rennie IG; Nichols CE; Sisley K
Cancer; 2008 Apr; 112(8):1787-94. PubMed ID: 18300240
[TBL] [Abstract][Full Text] [Related]
27. NBS1 expression as a prognostic marker in uveal melanoma.
Ehlers JP; Harbour JW
Clin Cancer Res; 2005 Mar; 11(5):1849-53. PubMed ID: 15756009
[TBL] [Abstract][Full Text] [Related]
28. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells.
Shaif-Muthana M; McIntyre C; Sisley K; Rennie I; Murray A
Cancer Res; 2000 Nov; 60(22):6441-7. PubMed ID: 11103811
[TBL] [Abstract][Full Text] [Related]
29. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Pushparaj V; Biswas J; Krishnakumar S
Curr Eye Res; 2007 Mar; 32(3):281-90. PubMed ID: 17453948
[TBL] [Abstract][Full Text] [Related]
30. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
31. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].
Beutelspacher SC; Serbecic N
Klin Monbl Augenheilkd; 2008 Aug; 225(8):703-7. PubMed ID: 18712654
[TBL] [Abstract][Full Text] [Related]
32. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y; Wilson MW
Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
[TBL] [Abstract][Full Text] [Related]
33. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
34. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.
Woodward JK; Elshaw SR; Murray AK; Nichols CE; Cross N; Laws D; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3144-52. PubMed ID: 12356817
[TBL] [Abstract][Full Text] [Related]
35. Analysis of clonality of tumour infiltrating lymphocytes in breast cancer and uveal melanoma.
Durie FH; George WD; Campbell AM; Damato BE
Immunol Lett; 1992 Aug; 33(3):263-9. PubMed ID: 1428001
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
37. Lymphocytic infiltration in uveal malignant melanoma.
de la Cruz PO; Specht CS; McLean IW
Cancer; 1990 Jan; 65(1):112-5. PubMed ID: 2293857
[TBL] [Abstract][Full Text] [Related]
38. Immune expression and inhibition of heat shock protein 90 in uveal melanoma.
Faingold D; Marshall JC; Antecka E; Di Cesare S; Odashiro AN; Bakalian S; Fernandes BF; Burnier MN
Clin Cancer Res; 2008 Feb; 14(3):847-55. PubMed ID: 18245548
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
40. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]